{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:57:48Z","timestamp":1740135468889,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Neutropenic enterocolitis (NE) is a potentially life-threatening disease that primarily occurs in cancer patients treated with chemotherapy. NE has substantial morbidity and mortality, and its incidence has increased with the widespread use of chemotherapeutic agents such as taxanes, gemcitabine, and leucovorin in patients with lung, breast, gastric, and ovarian cancers. Sometimes NE can be a possible cause of\u00a0death. Although, conservative approaches are often successful, there are currently no standardized treatment guidelines for NE and it is unclear when such strategies should be implemented. Therefore, we present this report to provide a greater insight into the possible treatment of NE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report the case of a 72-year-old woman with endometrial cancer who was undergoing treatment for hypertension, obesity and diabetes mellitus. The patient initially developed paralytic ileus on the 6th postoperative day (POD) after surgery for endometrial serous carcinoma. Complete recovery was achieved after 4\u00a0days of fasting and fluid replacement therapy. On the 27th POD, she received the first cycle of combination chemotherapy consisting of paclitaxel and carboplatin. On day 5 of chemotherapy, she developed the systemic inflammatory response syndrome including febrile neutropenia and sepsis. She then developed disseminated intravascular coagulation (DIC) and septic shock. The patient was subsequently moved to the intensive care unit (ICU). Despite initiating the standard treatment for septic shock and DIC, her overall status worsened. It was assumed that gut distention had led to bowel damage, subsequently leading to bacterial translocation. Thus, she developed NE with severe DIC and septic shock. We decided to reduce the intestinal pressure using an ileus tube to suction the additional air and fluid, even though doing so had a risk of worsening her general condition. The inflammatory reaction subsided, and her general condition improved. The patient recovered after 18\u00a0days in the ICU and was discharged alive.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Herein, we describe a patient with suspected chemotherapy-associated NE. Our observations suggest that postoperative ileus may be one of the possible causes of NE. Patients who experience postoperative ileus must be carefully monitored while undergoing chemotherapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-021-01302-8","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T10:03:10Z","timestamp":1620036190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Neutropenic enterocolitis-induced sepsis and disseminated intravascular coagulation after chemotherapy: a case report"],"prefix":"10.1186","volume":"21","author":[{"given":"Masako","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3250-3097","authenticated-orcid":false,"given":"Kentaro","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sultana","family":"Razia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoka","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoka","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Sasamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonomi","family":"Kurose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyoshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Kyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,3]]},"reference":[{"key":"1302_CR1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-3-319-43139-0_6","volume":"943","author":"N Eritja","year":"2017","unstructured":"Eritja N, Yeramian A, Chen BJ, Llobet-Navas D, Ortega E, Colas E, et al. Endometrial carcinoma: specific targeted pathways. Adv Exp Med Biol. 2017;943:149\u2013207.","journal-title":"Adv Exp Med Biol"},{"key":"1302_CR2","unstructured":"Cancer Registry and Statistics. Cancer Information Service, National Cancer Center, Japan."},{"key":"1302_CR3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejogrb.2019.09.007","volume":"242","author":"V Benito","year":"2019","unstructured":"Benito V, Lubrano A, And\u00fajar M, Mori M, Federico M. Management of endometrial cancer in patients aged 80 years and older: identifying patients who may benefit from a curative treatment. Eur J Obstet Gynecol Reprod Biol. 2019;242:36\u201342.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1302_CR4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2169\/internalmedicine.44.467","volume":"44","author":"M Furonaka","year":"2005","unstructured":"Furonaka M, Miyazaki M, Nakajima M, Hirata S, Fujitaka K, Kondo K, et al. Neutropenic enterocolitis in lung cancer: a report of two cases and a review of the literature. Intern Med. 2005;44:467\u201370.","journal-title":"Intern Med"},{"key":"1302_CR5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000421-200006000-00021","volume":"23","author":"C Kouroussis","year":"2000","unstructured":"Kouroussis C, Samonis G, Androulakis N, Souglakos J, Voloudaki A, Dimopoulos MA, et al. Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy: a report of five cases. Am J Clin Oncol. 2000;23:309\u201313.","journal-title":"Am J Clin Oncol"},{"key":"1302_CR6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.lungcan.2003.11.018","volume":"44","author":"G D\u2019Amato","year":"2004","unstructured":"D\u2019Amato G, Rocha Lima C, Mahany JJ, Muro-Cacho C, Haura EB. Neutropenic enterocolitis (typhlitis) associated with docetaxel therapy in a patient with non-small-cell lung cancer: case report and review of literature. Lung Cancer. 2004;44:381\u201390.","journal-title":"Lung Cancer"},{"key":"1302_CR7","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1200\/JCO.1998.16.5.1948","volume":"16","author":"J Zalcberg","year":"1998","unstructured":"Zalcberg J, Millward M, Bishop J, McKeage M, Zimet A, Toner G, et al. Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer. J Clin Oncol. 1998;16:1948\u201353.","journal-title":"J Clin Oncol"},{"key":"1302_CR8","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/annonc\/mdf084","volume":"13","author":"HJ Stemmler","year":"2002","unstructured":"Stemmler HJ, Kenngotte S, Diepolder H, Heinemann V. Gastrointestinal toxicity associated with weekly docetaxel treatment. Ann Oncol. 2002;13:978\u201381.","journal-title":"Ann Oncol"},{"key":"1302_CR9","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/jnci\/88.15.1078","volume":"88","author":"F Cardenal","year":"1996","unstructured":"Cardenal F, Montes A, Llort G, Segu\u00ed J, Mes\u00eda R. Typhlitis associated with docetaxel treatment. J Natl Cancer Inst. 1996;88:1078\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"1302_CR10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(99)06195-4","volume":"355","author":"NK Ibrahim","year":"2000","unstructured":"Ibrahim NK, Sahin AA, Dubrow RA, Lynch PM, Boehnke-Michaud L, Valero V, et al. Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer. Lancet. 2000;355:281\u20133.","journal-title":"Lancet"},{"key":"1302_CR11","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/1097-0142(19930301)71:5<1797::AID-CNCR2820710514>3.0.CO;2-B","volume":"71","author":"BC Pestalozzi","year":"1993","unstructured":"Pestalozzi BC, Sotos GA, Choyke PL, Fisherman JS, Cowan KH, O\u2019Shaughnessy JA. Typhlitis resulting from treatment with taxol and doxorubicin in patients with metastatic breast cancer. Cancer. 1993;71:1797\u2013800.","journal-title":"Cancer"},{"key":"1302_CR12","doi-asserted-by":"crossref","first-page":"bcr2014204035","DOI":"10.1136\/bcr-2014-204035","volume":"2014","author":"J Ramsingh","year":"2014","unstructured":"Ramsingh J, Bolln C, Hodnett R, Al-Ani A. Neutropenic enterocolitis affecting the transverse colon: an unusual complication of chemotherapy. BMJ Case Rep. 2014;2014:bcr2014204035.","journal-title":"BMJ Case Rep"},{"key":"1302_CR13","first-page":"29","volume":"40","author":"A Oehadian","year":"2008","unstructured":"Oehadian A, Fadjari TH. Neutropenic enterocolitis in breast cancer patient after taxane-containing chemotherapy. Acta Med Indones. 2008;40:29\u201333.","journal-title":"Acta Med Indones"},{"key":"1302_CR14","first-page":"2509","volume":"25","author":"A Gadducci","year":"2005","unstructured":"Gadducci A, Gargini A, Palla E, Fanucchi A, Genazzani AR. Neutropenic enterocolitis in an advanced epithelial ovarian cancer patient treated with paclitaxel\/platinum-based chemotherapy: a case report and review of the literature. Anticancer Res. 2005;25:2509\u201313.","journal-title":"Anticancer Res"},{"key":"1302_CR15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ygyno.2003.10.050","volume":"92","author":"JP Geisler","year":"2004","unstructured":"Geisler JP, Schraith DF, Manahan KJ, Sorosky JI. Gemcitabine associated vasculitis leading to necrotizing enterocolitis and death in women undergoing primary treatment for epithelial ovarian\/peritoneal cancer. Gynecol Oncol. 2004;92:705\u20137.","journal-title":"Gynecol Oncol"},{"key":"1302_CR16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/gyno.1997.4842","volume":"67","author":"VL Seewaldt","year":"1997","unstructured":"Seewaldt VL, Cain JM, Goff BA, Tamimi H, Greer B, Figge D. A retrospective review of paclitaxel-associated gastrointestinal necrosis in patients with epithelial ovarian cancer. Gynecol Oncol. 1997;67:137\u201340.","journal-title":"Gynecol Oncol"},{"key":"1302_CR17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/gyno.1995.1140","volume":"57","author":"PG Rose","year":"1995","unstructured":"Rose PG, Piver MS. Intestinal perforation secondary to paclitaxel. Gynecol Oncol. 1995;57:270\u20132.","journal-title":"Gynecol Oncol"},{"key":"1302_CR18","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0959-8049(02)00081-3","volume":"38","author":"MB Polee","year":"2002","unstructured":"Polee MB, Verweij J, Siersema PD, Tilanus HW, Splinter TA, Stoter G, et al. Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer. Eur J Cancer. 2002;38:1495\u2013500.","journal-title":"Eur J Cancer"},{"key":"1302_CR19","first-page":"44","volume":"22","author":"ML Davila","year":"2006","unstructured":"Davila ML. Neutropenic enterocolitis. Curr Opin Gastroenterol. 2006;22:44\u20137.","journal-title":"Curr Opin Gastroenterol"},{"key":"1302_CR20","first-page":"718","volume":"62","author":"I Mehdi","year":"2012","unstructured":"Mehdi I, Al BB. Chemotherapy-induced neutropenic necrotizing enterocolitis: a review. J Pak Med Assoc. 2012;62:718\u201323.","journal-title":"J Pak Med Assoc"},{"key":"1302_CR21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3748\/wjg.v23.i1.42","volume":"23","author":"FG Rodrigues","year":"2017","unstructured":"Rodrigues FG, Dasilva G, Wexner SD. Neutropenic enterocolitis. World J Gastroenterol. 2017;23:42\u20137.","journal-title":"World J Gastroenterol"},{"key":"1302_CR22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/clon.2003.0216","volume":"15","author":"A Olithselvan","year":"2003","unstructured":"Olithselvan A, Gorard DA. Vinorelbine and ischaemic colitis. Clin Oncol (R Coll Radiol). 2003;15:166\u20137.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1302_CR23","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0002-9343(79)90248-1","volume":"67","author":"GM Dosik","year":"1979","unstructured":"Dosik GM, Luna M, Valdivieso M, McCredie KB, Gehan EA, Gil-Extremera B, et al. Necrotizing colitis in patients with cancer. Am J Med. 1979;67:646\u201356.","journal-title":"Am J Med"},{"key":"1302_CR24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12094-006-0092-y","volume":"8","author":"AF Cardona Zorrilla","year":"2006","unstructured":"Cardona Zorrilla AF, Reveiz Herault L, Casasbuenas A, Aponte DM, Ramos PL. Systematic review of case reports concerning adults suffering from neutropenic enterocolitis. Clin Transl Oncol. 2006;8:31\u20138.","journal-title":"Clin Transl Oncol"},{"key":"1302_CR25","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archsurg.1990.01410210045006","volume":"125","author":"DS Wade","year":"1990","unstructured":"Wade DS, Douglass H Jr, Nava HR, Piedmonte M. Abdominal pain in neutropenic patients. Arch Surg. 1990;125:1119\u201327.","journal-title":"Arch Surg"},{"key":"1302_CR26","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0140-6736(05)73080-4","volume":"355","author":"O Sezer","year":"2000","unstructured":"Sezer O, Eucker J, Possinger K. Colitis associated with docetaxel based chemotherapy. Lancet. 2000;355:1823\u20134.","journal-title":"Lancet"},{"key":"1302_CR27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4291\/wjgp.v10.i3.36","volume":"10","author":"R Xia","year":"2019","unstructured":"Xia R, Zhang X. Neutropenic enterocolitis: a clinico-pathological review. World J Gastrointest Pathophysiol. 2019;10:36\u201341.","journal-title":"World J Gastrointest Pathophysiol"},{"key":"1302_CR28","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/00005373-200010000-00029","volume":"49","author":"C Bibbo","year":"2000","unstructured":"Bibbo C, Barbieri RA, Deitch EA, Brolin RE. Neutropenic enterocolitis in a trauma patient during antibiotic therapy for osteomyelitis. J Trauma. 2000;49:760\u20133.","journal-title":"J Trauma"},{"key":"1302_CR29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/rheumatology\/31.5.351","volume":"31","author":"K Chakravarty","year":"1992","unstructured":"Chakravarty K, Scott DG, McCann BG. Fatal neutropenic enterocolitis associated with sulphasalazine therapy for rheumatoid arthritis. Br J Rheumatol. 1992;31:351\u20132.","journal-title":"Br J Rheumatol"},{"key":"1302_CR30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2006.02.012","volume":"103","author":"S Sharma","year":"2006","unstructured":"Sharma S, Rezai K, Driscoll D, Odunsi K, Lele S. Characterization of neutropenic fever in patients receiving first-line adjuvant chemotherapy for epithelial ovarian cancer. Gynecol Oncol. 2006;103:181\u20135.","journal-title":"Gynecol Oncol"},{"key":"1302_CR31","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ygyno.2003.11.005","volume":"92","author":"J Markman","year":"2004","unstructured":"Markman J, Zanotti K, Webster K, Belinson J, Peterson G, Kulp B, et al. Experience with the management of neutropenia in gynecologic cancer patients receiving carboplatin-based chemotherapy. Gynecol Oncol. 2004;92:592\u20135.","journal-title":"Gynecol Oncol"},{"key":"1302_CR32","doi-asserted-by":"crossref","first-page":"omz140","DOI":"10.1093\/omcr\/omz122","volume":"2019","author":"DR Principe","year":"2019","unstructured":"Principe DR, Koch RM, Bergsten TM, Rubin J. Chemotherapy-associated neutropenic enterocolitis of the transverse colon post right hemicolectomy. Oxf Med Case Rep. 2019;2019:omz140.","journal-title":"Oxf Med Case Rep"},{"key":"1302_CR33","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0140-6736(06)69251-9","volume":"368","author":"A Romero-Corral","year":"2006","unstructured":"Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368:666\u201378.","journal-title":"Lancet"},{"key":"1302_CR34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.2012.113905","volume":"309","author":"KM Flegal","year":"2013","unstructured":"Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309:71\u201382.","journal-title":"JAMA"},{"key":"1302_CR35","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1241244","volume":"341","author":"RS Ahima","year":"2013","unstructured":"Ahima RS, Lazar MA. Physiology The health risk of obesity\u2013better metrics imperative. Science. 2013;341:856\u20138.","journal-title":"Science"},{"issue":"20","key":"1302_CR36","first-page":"1","volume":"15","author":"DJ Pepper","year":"2016","unstructured":"Pepper DJ, Sun J, Welsh J, Cui X, Suffredini AF, Eichacker PQ. Increased body mass index and adjusted mortality in ICU patients with sepsis or septic shock: a systematic review and meta-analysis. Crit Care. 2016;15(20):1.","journal-title":"Crit Care"},{"key":"1302_CR37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12871-017-0405-4","volume":"17","author":"S Wang","year":"2017","unstructured":"Wang S, Liu X, Chen Q, Liu C, Huang C, Fang X. The role of increased body mass index in outcomes of sepsis: a systematic review and meta-analysis. BMC Anesthesiol. 2017;17:118.","journal-title":"BMC Anesthesiol"},{"key":"1302_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12871-016-0295-x","volume":"17","author":"PY Ng","year":"2017","unstructured":"Ng PY, Eikermann M. The obesity conundrum in sepsis. BMC Anesthesiol. 2017;17:1.","journal-title":"BMC Anesthesiol"},{"key":"1302_CR39","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/oby.2007.102","volume":"16","author":"H Oliveros","year":"2008","unstructured":"Oliveros H, Villamor E. Obesity and mortality in critically ill adults: a systematic review and meta-analysis. Obesity (Silver Spring). 2008;16:515.","journal-title":"Obesity (Silver Spring)"},{"key":"1302_CR40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00508-009-1241-4","volume":"122","author":"B Wurzinger","year":"2010","unstructured":"Wurzinger B, D\u00fcnser MW, Wohlmuth C, Deutinger MC, Ulmer H, Torgersen C, et al. The association between body-mass index and patient outcome in septic shock: a retrospective cohort study. Wien Klin Wochenschr. 2010;122:31\u20136.","journal-title":"Wien Klin Wochenschr"},{"key":"1302_CR41","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1007\/s00134-009-1424-5","volume":"35","author":"CW Hogue Jr","year":"2009","unstructured":"Hogue CW Jr, Stearns JD, Colantuoni E, Robinson KA, Stierer T, Mitter N, et al. The impact of obesity on outcomes after critical illness: a meta-analysis. Intensive Care Med. 2009;35:1152\u201370.","journal-title":"Intensive Care Med"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-021-01302-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-021-01302-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-021-01302-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T10:07:33Z","timestamp":1620036453000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-021-01302-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1302"],"URL":"https:\/\/doi.org\/10.1186\/s12905-021-01302-8","relation":{},"ISSN":["1472-6874"],"issn-type":[{"type":"electronic","value":"1472-6874"}],"subject":[],"published":{"date-parts":[[2021,5,3]]},"assertion":[{"value":"28 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The case report protocol was approved by the institutional ethics and research review boards at Shimane University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was collected from the patient\u2019s son for the publication of this case report. Her son is an adult male. A copy of the written consent is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}